1. miR‐744‐5p inhibits cellular proliferation and invasion via targeting ARF1 in epithelial ovarian cancer
   Lai‐Gang Zhao et al, 2020, The Kaohsiung Journal of Medical Sciences CrossRef
2. Disease-related cellular protein networks differentially affected under different EGFR mutations in lung adenocarcinoma
   Toshihide Nishimura et al, 2020, Scientific Reports CrossRef
3. Distinct role of TGN-resident clathrin adaptors for Vps21p activation in the TGN–endosome trafficking pathway
   Makoto Nagano et al, 2023, Journal of Cell Science CrossRef
4. Spatial intratumoural heterogeneity in the expression of GIT1 is associated with poor prognostic outcome in oestrogen receptor positive breast cancer patients with synchronous lymph node metastases
   Ibai Goicoechea et al, 2018, F1000Research CrossRef
5. Golgi Complex: A Signaling Hub in Cancer
   Daniela Spano et al, 2022, Cells CrossRef
6. The Role of ARF Family Proteins and Their Regulators and Effectors in Cancer Progression: A Therapeutic Perspective
   Cristina Casalou et al, 2020, Frontiers in Cell and Developmental Biology CrossRef
7. Chlortetracycline, a Novel Arf Inhibitor That Decreases the Arf6-Dependent Invasive Properties of Breast Cancer Cells
   Eric Macia et al, 2021, Molecules CrossRef
8. Plumbagin suppresses non-small cell lung cancer progression through downregulating ARF1 and by elevating CD8+ T cells
   Ze-Bo Jiang et al, 2021, Pharmacological Research CrossRef
9. Cross-Kingdom Activation of Vibrio Toxins by ADP-Ribosylation Factor Family GTPases
   Alfa Herrera et al, 2020, Journal of Bacteriology CrossRef
10. LncRNA TP73‐AS1 is a novel regulator in cervical cancer via miR‐329‐3p/ARF1 axis
    Jingning Xu et al, 2020, Journal of Cellular Biochemistry CrossRef
11. Up-regulated ADP-Ribosylation factor 3 promotes breast cancer cell proliferation through the participation of FOXO1
    Danping Huang et al, 2019, Experimental Cell Research CrossRef
12. KLHL14: A Novel Prognostic Biomarker and Therapeutic Target for Ovarian Cancer
    Xingwei Wang et al, 2022, Journal of Oncology CrossRef
13. Potentiating Therapeutic Effects of Epidermal Growth Factor Receptor Inhibition in Triple-Negative Breast Cancer
    Kyu Sic You et al, 2021, Pharmaceuticals CrossRef
14. The Arf-GAP and protein scaffold Cat1/Git1 as a multifaceted regulator of cancer progression
    Sungsoo M. Yoo et al, 2020, Small GTPases CrossRef
15. Role of the Mosaic Cisternal Maturation Machinery in Glycan Synthesis and Oncogenesis
    P. Sahu et al, 2022, Frontiers in Cell and Developmental Biology CrossRef
16. Cell type specific cytoskeleton disruption induced by engineered nanoparticles
    Octavio Ispanixtlahuatl-Meráz et al, 2018, Environmental Science: Nano CrossRef
17. Cross Talk between ARF1 and RhoA Coordinates the Formation of Cytoskeletal Scaffolds during Chlamydia Infection
    Adam Haines et al, 2021, mBio CrossRef
18. Functional disruption of the Golgi apparatus protein ARF1 sensitizes MDA-MB-231 breast cancer cells to the antitumor drugs Actinomycin D and Vinblastine through ERK and AKT signaling
    Charlotte Luchsinger et al, 2018, PLOS ONE CrossRef
19. Downregulation of long non-coding RNA LINC00460 inhibits the proliferation, migration and invasion, and promotes apoptosis of pancreatic cancer cells via modulation of the miR-320b/ARF1 axis
    Jian Cheng et al, 2021, Bioengineered CrossRef